Cancer and pregnancy

Recent developments

Renée M. Ward, Robert E. Bristow

Research output: Contribution to journalArticle

Abstract

Purpose of review: Breast carcinoma, cervical dysplasia and cervical carcinoma are some of the most common forms of precancerous and malignant changes seen in pregnancy due to their prevalence in reproductive age women. The impact of pregnancy on these diseases is complex and needs to be carefully considered for appropriate clinical management. Recent findings: Recent studies indicate a relationship between hormone levels during pregnancy and subsequent breast cancer risk. For women who have already been diagnosed with breast cancer, retrospective studies show no adverse outcomes on maternal mortality with subsequent pregnancy. Prospective studies are needed to further elucidate these relationships. Recent research evaluating human papilloma virus in pregnant women indicates a similar prevalence of disease among pregnant and nonpregnant patients. Increased rates of human papilloma virus clearance postpartum may be related to an increased immune response within the cervix secondary to the trauma of labor. For women with early stage cervical cancer desiring to preserve future fertility, new trends in treatment allow for preservation of reproductive function. Few recent studies have been conducted regarding the use of chemotherapy during pregnancy, but one study reports increased rates of prematurity after the use of chemotherapy. Summary: Continued research is needed regarding the management of breast and cervical cancer during pregnancy in order to optimize treatments and to further our understanding of these disease processes.

Original languageEnglish (US)
Pages (from-to)613-617
Number of pages5
JournalCurrent Opinion in Obstetrics and Gynecology
Volume14
Issue number6
DOIs
StatePublished - Dec 2002

Fingerprint

Papillomaviridae
Pregnancy
Breast Neoplasms
Neoplasms
Uterine Cervical Neoplasms
Uterine Cervical Dysplasia
Drug Therapy
Maternal Mortality
Research
Cervix Uteri
Postpartum Period
Fertility
Pregnant Women
Retrospective Studies
Hormones
Prospective Studies
Carcinoma
Therapeutics

Keywords

  • Breast cancer
  • Cervical neoplasic
  • Pregnancy

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Cancer and pregnancy : Recent developments. / Ward, Renée M.; Bristow, Robert E.

In: Current Opinion in Obstetrics and Gynecology, Vol. 14, No. 6, 12.2002, p. 613-617.

Research output: Contribution to journalArticle

Ward, Renée M. ; Bristow, Robert E. / Cancer and pregnancy : Recent developments. In: Current Opinion in Obstetrics and Gynecology. 2002 ; Vol. 14, No. 6. pp. 613-617.
@article{daf28c03027d4c58ad8cef68397bd01b,
title = "Cancer and pregnancy: Recent developments",
abstract = "Purpose of review: Breast carcinoma, cervical dysplasia and cervical carcinoma are some of the most common forms of precancerous and malignant changes seen in pregnancy due to their prevalence in reproductive age women. The impact of pregnancy on these diseases is complex and needs to be carefully considered for appropriate clinical management. Recent findings: Recent studies indicate a relationship between hormone levels during pregnancy and subsequent breast cancer risk. For women who have already been diagnosed with breast cancer, retrospective studies show no adverse outcomes on maternal mortality with subsequent pregnancy. Prospective studies are needed to further elucidate these relationships. Recent research evaluating human papilloma virus in pregnant women indicates a similar prevalence of disease among pregnant and nonpregnant patients. Increased rates of human papilloma virus clearance postpartum may be related to an increased immune response within the cervix secondary to the trauma of labor. For women with early stage cervical cancer desiring to preserve future fertility, new trends in treatment allow for preservation of reproductive function. Few recent studies have been conducted regarding the use of chemotherapy during pregnancy, but one study reports increased rates of prematurity after the use of chemotherapy. Summary: Continued research is needed regarding the management of breast and cervical cancer during pregnancy in order to optimize treatments and to further our understanding of these disease processes.",
keywords = "Breast cancer, Cervical neoplasic, Pregnancy",
author = "Ward, {Ren{\'e}e M.} and Bristow, {Robert E.}",
year = "2002",
month = "12",
doi = "10.1097/00001703-200212000-00007",
language = "English (US)",
volume = "14",
pages = "613--617",
journal = "Current Opinion in Obstetrics and Gynecology",
issn = "1040-872X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Cancer and pregnancy

T2 - Recent developments

AU - Ward, Renée M.

AU - Bristow, Robert E.

PY - 2002/12

Y1 - 2002/12

N2 - Purpose of review: Breast carcinoma, cervical dysplasia and cervical carcinoma are some of the most common forms of precancerous and malignant changes seen in pregnancy due to their prevalence in reproductive age women. The impact of pregnancy on these diseases is complex and needs to be carefully considered for appropriate clinical management. Recent findings: Recent studies indicate a relationship between hormone levels during pregnancy and subsequent breast cancer risk. For women who have already been diagnosed with breast cancer, retrospective studies show no adverse outcomes on maternal mortality with subsequent pregnancy. Prospective studies are needed to further elucidate these relationships. Recent research evaluating human papilloma virus in pregnant women indicates a similar prevalence of disease among pregnant and nonpregnant patients. Increased rates of human papilloma virus clearance postpartum may be related to an increased immune response within the cervix secondary to the trauma of labor. For women with early stage cervical cancer desiring to preserve future fertility, new trends in treatment allow for preservation of reproductive function. Few recent studies have been conducted regarding the use of chemotherapy during pregnancy, but one study reports increased rates of prematurity after the use of chemotherapy. Summary: Continued research is needed regarding the management of breast and cervical cancer during pregnancy in order to optimize treatments and to further our understanding of these disease processes.

AB - Purpose of review: Breast carcinoma, cervical dysplasia and cervical carcinoma are some of the most common forms of precancerous and malignant changes seen in pregnancy due to their prevalence in reproductive age women. The impact of pregnancy on these diseases is complex and needs to be carefully considered for appropriate clinical management. Recent findings: Recent studies indicate a relationship between hormone levels during pregnancy and subsequent breast cancer risk. For women who have already been diagnosed with breast cancer, retrospective studies show no adverse outcomes on maternal mortality with subsequent pregnancy. Prospective studies are needed to further elucidate these relationships. Recent research evaluating human papilloma virus in pregnant women indicates a similar prevalence of disease among pregnant and nonpregnant patients. Increased rates of human papilloma virus clearance postpartum may be related to an increased immune response within the cervix secondary to the trauma of labor. For women with early stage cervical cancer desiring to preserve future fertility, new trends in treatment allow for preservation of reproductive function. Few recent studies have been conducted regarding the use of chemotherapy during pregnancy, but one study reports increased rates of prematurity after the use of chemotherapy. Summary: Continued research is needed regarding the management of breast and cervical cancer during pregnancy in order to optimize treatments and to further our understanding of these disease processes.

KW - Breast cancer

KW - Cervical neoplasic

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=0036913317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036913317&partnerID=8YFLogxK

U2 - 10.1097/00001703-200212000-00007

DO - 10.1097/00001703-200212000-00007

M3 - Article

VL - 14

SP - 613

EP - 617

JO - Current Opinion in Obstetrics and Gynecology

JF - Current Opinion in Obstetrics and Gynecology

SN - 1040-872X

IS - 6

ER -